We found that the RHOA, MAPK4, SGK494, DOT1L, SETD2, ME3 and DLAT genes were significantly differentially expressed in the livers of the BBR and DM groups and thus are potential targets for the treatment of T2DM. The gene discussed is ME3; the disease is type 2 diabetes mellitus.